Cargando…
Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal
In September 2020, we tested 13,398 persons in Portugal for antibodies against severe acute respiratory syndrome coronavirus 2 by using a quota sample stratified by age and population density. We found a seroprevalence of 2.2%, 3–4 times larger than the official number of cases at the end of the fir...
Autores principales: | Canto e Castro, Luísa, Pereira, Ana Helena Guia, Ribeiro, Rita, Alves, Catarina, Veloso, Luís, Vicente, Vera, Alves, Dalila, Domingues, Inês, Silva, Cláudia, Gomes, Andreia, Serrano, Marta, Afonso, Ângela, Veldhoen, Marc, de Sousa, Maria José Rego, de Sousa, José Germano Rego, de Sousa, Germano, Mota, Maria M., Silva-Santos, Bruno, Ribeiro, Ruy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544986/ https://www.ncbi.nlm.nih.gov/pubmed/34437830 http://dx.doi.org/10.3201/eid2711.210636 |
Ejemplares similares
-
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection
por: Canto e Castro, Luísa, et al.
Publicado: (2021) -
Rickettsia slovaca Infection in Humans, Portugal
por: de Sousa, Rita, et al.
Publicado: (2013) -
Early Growth and Neurologic Outcomes of Infants with Probable Congenital Zika Virus Syndrome
por: Moura da Silva, Antonio Augusto, et al.
Publicado: (2016) -
Imipenem Resistance in Clostridium difficile Ribotype 017, Portugal
por: Isidro, Joana, et al.
Publicado: (2018) -
Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal
por: Ribeiro, Joana, et al.
Publicado: (2017)